Title 23 — Health and Safety
97 chapters · 659 sections in this title.
N.D.C.C. § 23-50-01 Drug fatalities review panel
1.3K chars
1. The forensic pathology department of the university of North Dakota school of medicine and health sciences shall appoint individuals to serve as members on the drug fatalities review panel. To encompass disciplines needed for evaluation and balance of members' viewpoints, pane…
N.D.C.C. § 23-50-02 Powers and duties
1.9K chars
1. The panel may: a. Provide outcome data on drug-related fatalities in the state as a basis for policy, intervention, and other program effectiveness. b. Promote the identification of circumstances that may contribute to drug-related fatalities. c. Promote the identification of …
N.D.C.C. § 23-50-03 Confidentiality
0.4K chars
Notwithstanding section 44-04-19, all portions of a meeting of the panel which reviews drug fatalities are closed to the public. Notwithstanding section 44-04-18, all documentation and reports of the panel which are related to panel review of drug fatalities are confidential, exc…
N.D.C.C. § 23-50-04 Access to records
0.3K chars
Upon the written request of the presiding officer of the panel, a health care facility and health care provider shall disclose all patient records of the facility or provider which are requested by the panel and pertain to an identified drug fatality. The presiding officer may re…
N.D.C.C. § 23-50-05 State report
0.2K chars
Annually the panel shall compile a state report of fatalities reviewed. The report must include identification of patterns, trends, and policy issues related to drug fatalities, but may not disclose personally identifiable information.